GSK reaches settlement in US Zantac litigation
(Reuters) -GSK Plc on Friday said it reached a confidential settlement of a litigation in the United States over claims
1970-01-01 08:00
GSK Settles First Zantac Cancer Lawsuit Set for Trial in US
GSK Plc reached a settlement with a man who claimed the drugmaker’s blockbuster heartburn medication Zantac caused his
1970-01-01 08:00
GSK's RSV vaccine shows long-term efficacy in late-stage trial
(Reuters) -GSK on Wednesday said its vaccine for the respiratory syncytial virus (RSV), which recently won EU approval, showed strong
1970-01-01 08:00
Only Labour Can Fix the NHS, Says Boris Johnson’s Vaccine Czar
The National Health Service is “hopeless” and needs a “complete restructuring,” says the woman behind one of its
1970-01-01 08:00
EU approves its first vaccine for common respiratory virus RSV
By Natalie Grover and Eva Mathews (Reuters) -European regulators have approved the region's first vaccine for respiratory syncytial virus (RSV),
1970-01-01 08:00
GSK's cancer drug Jemperli gets file acceptance from US FDA
GSK said on Tuesday that the U.S. Food and Drug Administration had granted file acceptance for its cancer
1970-01-01 08:00
French Drugmaker Weighs Bids For Scottish Site Behind Covid Debacle
Valneva SE has been approached by about a dozen potential buyers for its Scottish manufacturing site, according to
1970-01-01 08:00
Concrete Giant Plans Formal Vote on US Listing: The London Rush
When building materials company CRH said it planned to move its primary listing to the US in March
1970-01-01 08:00
Macron Asks Business to ‘Choose France’ as He Seeks Agenda Reset
French President Emmanuel Macron has invited about 200 global business leaders to Versailles on Monday, showcasing his foreign
1970-01-01 08:00
GSK Raises $1 Billion Selling Shares in Haleon Consumer Spinoff
GSK Plc raised £804 million ($1 billion) selling a stake in Haleon Plc, the consumer health-care division it
1970-01-01 08:00